Revolution Medicines
Price & Volume
Stats
See more52W Range | $29.17-$62.40 |
Market Cap | $7.5B |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $742,000 |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$592.2M |
Diluted EPS | -$3.58 |
News
See moreYahoo Finance • 4 days ago
Revolution Medicines Presents Initial Data from Zoldonrasib (RMC-9805) Study in Patients with KRAS G12D Mutant Non-Small Cell Lung Cancer at the 2025 AACR Annual Meeting
Yahoo Finance • 23 days ago
Barbara Weber, M.D., Elected to ITM Supervisory Board
Yahoo Finance • 30 days ago
Revolution Medicines to Deliver Multiple Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting
Yahoo Finance • last month
Revolution Medicines to Participate in April 2025 Investor Conferences
About
CEO | Dr. Mark A. Goldsmith Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 534 |
